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Abstract
Background—Fear acquisition and extinction are central constructs in the cognitive-behavioral 
model of obsessive-compulsive disorder (OCD), which underlies exposure-based cognitive-
behavioral therapy (CBT). Youth with OCD may have impairments in fear acquisition and 
extinction that carry treatment implications. We examined these processes using a differential 
conditioning procedure.
Methods—Forty-one youth (19 OCD, 22 community comparisons) completed a battery of 
clinical interviews, rating scales, and a differential conditioning task that included habituation, 
acquisition, and extinction phases. Skin conductance response (SCR) served as the primary 
dependent measure.
Results—During habituation, no difference between groups was observed. During acquisition, 
differential fear conditioning was observed across participants as evidenced by larger SCRs to the 
CS+ compared to CS−; there were no between-group differences. Across participants, the number 
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and frequency of OCD symptoms and anxiety severity was associated with greater reactivity to 
stimuli during acquisition. During extinction, a three-way interaction and follow-up tests revealed 
that youth with OCD showed a different pattern of SCR extinction compared to the community 
comparison group.
Conclusions—Youth with OCD exhibit a different pattern of fear extinction relative to 
community comparisons. This may be attributed to impaired inhibitory learning and contingency 
awareness in extinction. Findings suggest the potential benefit of utilizing inhibitory-learning 
principles in CBT for youth with OCD, and/or augmentative retraining interventions prior to CBT 
to reduce threat bias and improve contingency detection.
Keywords
Fear conditioning; extinction; skin conductance; inhibitory learning; obsessive compulsive 
disorder; children
Introduction
Obsessive-compulsive disorder (OCD) is characterized by the presence of obsessions and/or 
compulsions that affect approximately 1–2% of the population,[1] with a majority of 
individuals reporting symptom onset during childhood.[2] Youth with OCD experience 
functional impairment,[3] and impaired quality of life.[4] Although multiple factors have 
been implicated in the etiology of OCD,[5] the cognitive-behavioral model[6] underlies the 
front-line treatment, viz., exposure-based cognitive-behavioral therapy.[7]
In the cognitive-behavioral model, the mechanisms of fear acquisition and extinction play an 
important role in symptom development, maintenance and treatment of OCD. Conditioned 
fear occurs when an emotionally neutral stimulus (conditioned stimulus, CS) is paired with 
an aversive unconditioned stimulus (US). Although not a conventional US like a shock, 
obsessions are purported to serve as the US in OCD (e.g., fear that a door handle is 
contaminated and that contact will cause severe illness/death). Subsequent exposures to the 
CS become capable of producing a conditioned response (CR) such as fear/distress. Some 
individuals with OCD generalize these learned associations to other stimuli creating a "chain 
of contagion".[8] Thus, these individuals have difficulty discriminating between perceived 
and actually dangerous stimuli. Extinction is a learning process whereby the response to the 
CS declines through repeated exposure in the absence of the feared outcome (e.g., illness/
death) and/or engagement in safety behaviors (e.g., avoidance, compulsive rituals). This 
process does not eradicate the initial CS-US association, but rather forms a new CS-no US 
association that inhibits the existing dysfunctional CS-US association.[9] Over repeated 
exposures to the CS, the original fear/distress response (CR) becomes inhibited.[9]
Despite the presumed central role in OCD, limited empirical data on conditioned fear 
acquisition and extinction derive primarily from adults with other anxiety disorders.[10–13] 
Only two studies of adults with OCD have examined fear learning using Pavlovian fear 
conditioning tasks and skin conductance responses (SCRs).[14, 15] Nanbu and colleagues[14] 
used a classical conditioning task, and found no significant difference between adults with 
OCD and healthy controls. Meanwhile, Milad and colleagues[15] used a differential 
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conditioning task and found no significant difference in either fear acquisition or extinction 
learning between adults with OCD and healthy controls. However, Milad and colleagues[15] 
did observe impaired extinction recall in adults with OCD, compared to healthy controls. 
Despite methodological differences, findings collectively suggest that adults with OCD 
demonstrate comparable differential fear conditioning and extinction learning relative to 
community comparisons.[14, 15] Age differences have been found for both differential fear 
conditioning[16–18] and the neurobiology underlying fear acquisition and extinction between 
youth and adults.[16, 19] Moreover, there are considerable phenomenological distinctions 
between adults and youth with OCD that limit the generalization of findings.[20]
To date, there has been no published examination of conditioned fear acquisition and 
extinction in youth with OCD compared to community comparisons. Notably, a few studies 
have compared fear conditioning in youth with anxiety disorders and community 
comparisons.[21–27] Findings suggest that fear conditioning produces comparable differential 
fear learning in anxious and non-anxious youth during acquisition; however, results for 
extinction are less definitive. Some evidence suggests that anxious youth exhibit resistance 
to within-session extinction,[21–23, 25] and/or show larger CRs to stimuli after 
extinction.[23, 25, 26] Conversely, other findings suggest that there is no significant difference 
in extinction,[19, 27] with both anxious and non-anxious youth exhibiting comparable 
extinction of the CR.[24] These inconsistencies may be attributable to differences in sample 
characteristics, conditioning procedures, outcome measures, and unconditioned stimuli.[19]
Even though a fear conditioning model may not account for the entire phenomenology of 
OCD (e.g., not-just-right experiences, disgust),[28, 29] understanding fear conditioning in 
youth with OCD is clinically relevant. First, as OCD typically onsets in childhood,[2] 
examining fear acquisition and extinction processes closer to symptom onset may help to 
identify whether impairments in these processes contribute to OCD phenomenology. 
Second, a considerable portion of youth with OCD exhibit inadequate or incomplete 
response to CBT. In the Pediatric OCD Treatment Study, up to 25% of youth did not respond 
to exposure-based CBT and 60% of youth remained symptomatic after treatment.[30] Given 
the central role that fear conditioning concepts are accorded in CBT, a better understanding 
of these mechanisms may improve treatment outcome. For example, it may be that youth 
with OCD who demonstrate typical fear acquisition and extinction will benefit from 
standard CBT approaches. However, youth who show impaired extinction might benefit 
from augmentative interventions to retrain attention/cognitive/threat biases before initiating 
CBT to achieve optimal benefit,[31, 32] or CBT approaches that emphasize engagement of 
specific brain regions implicated in extinction among youth.[16] Finally, improved 
understanding of conditioned fear in OCD may help to guide future research.
The present study examined fear conditioning and extinction in youth with OCD and healthy 
community comparisons (CC) using a differential conditioning task. We tested two primary 
hypotheses. First, we hypothesized that youth with OCD would exhibit poorer extinction of 
a fear-conditioned SCR compared to CC. Second, given prior associations between lower 
OCD severity and improved CBT outcomes,[33–35] we hypothesized that greater OCD 
severity would be associated with poorer fear extinction. Finally, we examined the 
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associations between anxiety severity and anxiety sensitivity to determine whether deficits in 
extinction were related to co-occurring anxiety symptoms.
Methods
Participants
Participants were recruited through a southeastern OCD specialty clinic and the surrounding 
community using flyers posted in community locations and by word-of-mouth. Interested 
participants completed a phone screen interview with the first author to determine possible 
eligibility. Inclusion criteria for OCD participants were: a primary diagnosis of OCD based 
on a clinical interview, 7–17 years of age, and English speaking. Exclusion criteria for youth 
with OCD included: the presence of autism spectrum disorder, mental retardation, psychosis, 
bipolar disorder, posttraumatic stress disorder, conduct disorder, or schizophrenia. 
Psychiatric medication was permissible and no participant had any medication changes 
reported within eight weeks prior to participation. Inclusion criteria for CC included: the 
absence of any psychiatric disorder other than specific phobia as determined by a clinical 
interview, 7–17 years of age, and English speaking.
A total of 57 participants underwent differential fear conditioning. Seven participants (4 
OCD, 3 CC) discontinued the study during the acquisition phase, with 50 participants 
completing the entire fear conditioning procedure. Several participants’ data were excluded 
from analyses due to unreliable recording of SC activity (n=4) and small mean SCRs to the 
US (n=4). Data from 1 OCD participant was excluded due to missing parent and self-report 
measures. The final sample consisted of 41 youth (19 OCD, 22 CC) between 8 and 17 years 
of age. There were no significant differences in demographic characteristics between the 
original and final sample.
Measures
Schedule for Affective Disorders and Schizophrenia for School-Age Children 
Present and Lifetime Version (KSADS-PL)—The KSADS-PL is a clinician-
administered interview for DSM-IV childhood disorders that has demonstrated excellent 
reliability and validity.[36] The rates of OCD, anxiety disorders, and other comorbid 
conditions are reported in Table 1.
Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS)—The CY-
BOCS is a clinician-administered measure that is the gold-standard metric of obsessive-
compulsive symptom severity in youth.[37] The CY-BOCS consists of a symptom checklist 
and 10 severity items that are summed for a total severity score. The CY-BOCS has 
demonstrated strong psychometric properties.[37, 38]
Obsessive-Compulsive Inventory-Child Version (OCI-CV)—The OCI-CV is a 21-
item child-report measure that assesses the presence and frequency of OCD symptoms. 
Items rated on 3-point scale, and are summed to yield a total score.[39] The OCI-CV has 
good reliability and validity among youth with OCD.[39, 40]
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Multidimensional Anxiety Scale for Children (MASC)—The MASC is a 39-item 
child-report questionnaire that assesses anxiety severity.[41] Items are rated on a 4-point 
scale and summed to produce a total score that is adjusted for age and gender (T-score). The 
MASC has good reliability and validity in youth.[41]
Anxiety Sensitivity Index-3 (ASI-3)—The ASI-3 is an 18-item patient-rated measure 
that assessed beliefs about the feared consequences of symptoms associated with anxious 
arousal.[42] Items are summed to produce a total anxiety sensitivity score. The ASI-3 has 
good reliability and validity.[42]
Fear Conditioning Task—A differential fear conditioning procedure was administered, 
whereby a 95 decibel scream and fearful facial expression (US) was paired with a neutral 
female face (CS+) but not with a second neutral female face (CS−). During a habituation 
phase, participants passively viewed 4 presentations each of the to-be CS+ and CS− without 
the US. The stimulus presentation order was held constant to minimize procedural 
variability. During the acquisition phase, the CS+ female face was paired with the US for 8 
of 10 presentations; the CS− female face was never paired with the US. The US duration 
was 3 seconds; its onset immediately followed the offset of the CS+. During the extinction 
phase, there were 8 presentations each of the CS+ and CS− in the absence of the US. These 
stimuli and US have been used in studies of children with anxiety disorders[16, 24] and 
healthy comparisons.[17] Skin conductance response served as the primary dependent 
measure of fear acquisition and extinction, with larger SCR values suggesting greater fear.
Procedure
All study procedures were approved by the local institutional review board. After written 
parental consent and child assent were obtained, parents and youth completed the KSADS-
PL to determine eligibility and the CY-BOCS. Next, youth completed the OCI-CV, MASC, 
and ASI-3. Afterward, youth completed the fear conditioning task. Participants were 
informed that they could discontinue participation at anytime. Youth and families were 
collectively compensated $30.
Data Analysis
The SCR score for each CS presentation was calculated by subtracting the average SC level 
during the 2-second interval immediately preceding CS onset from the peak SC level during 
the 8-second CS interval. For the UCR, a SCR score for each US presentation was calculated 
by subtracting the average SC level during the last 2 seconds of the CS interval from the 
peak SC level during the 5-second interval following US onset. In order to address skewness 
in the SCR distribution, a square-root transformation was applied to the absolute values of 
all SCRs prior to analysis. If a SCR was negative, the minus sign was replaced following the 
square-root transformation. SCR values were evaluated to determine potential measurement 
failure and/or that there was an appropriately large average response to the US (SCR≥.50 
µS). Trial-block scores were created by calculating the average SCR to successive blocks of 
2 trials of the same trial type. This produced 2 blocks each for the CS+ and CS− for the 
habituation phase, 5 blocks for the acquisition phase, and 4 blocks for the extinction phase. 
Consistent with previous work,[11, 24] a repeated-measures analysis of variance (ANOVA) 
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was conducted with diagnostic group (OCD, CC) as a between-group factor, stimulus type 
(CS+, CS−) as a within-group factor, and trial block as the repeated measure for each phase. 
Independent sample t-tests were used to compare orienting responses (the first presentations 
of the CS+ and CS−) between groups and averaged unconditioned response to the US across 
trials. Additionally, the unconditioned response to the US was compared between groups 
using a repeated-measure ANOVA. For all repeated-measure ANOVAs, significance levels 
reflect the Greenhouse-Geisser correction for sphericity. Because age may influence fear 
acquisition and extinction,[18] analyses were reexamined using only those participants 
matched for gender and age within two years (n=38, 19 OCD, 19 CC). There were no 
substantive differences in findings, with the noted exception of the three-way interaction in 
the extinction phase that reached statistical significance and is reported below. Pearson 
correlations examined associations between clinical characteristics and the average SCR for 
the CS+, CS−, and their differential score (difference between the CS+ and CS−) within 
each phase. Given the preliminary nature of fear conditioning analyses among youth with 
OCD, statistical significance was set at p=.05 for all analyses.[27]
Results
Participants
Comparisons of sample characteristics are presented in Table 1. Although the groups did not 
differ in age or gender, there was a non-significant trend towards fewer Caucasians among 
community comparisons. Youth with OCD were more likely to be taking a serotonin 
reuptake inhibitor (SRI) medication compared to community comparisons (p<.001), with no 
significant difference found for other psychiatric medication types.
Habituation phase and orienting response
There was no significant group difference in the SC orienting response magnitudes, i.e., 
SCRs to the first CS+ presentation (t39=.34, p=.74, d=.11) or the first CS− presentation 
(t39=.21, p=.84, d=.05). Table 2 provides results from repeated-measures ANOVA for the 
habituation phase. There was a main effect for trial block that approached significance and 
reflected larger SCRs to the first trial block, compared to the second trial block. 
Additionally, there was a significant stimulus × trial block interaction. This interaction 
reflects a greater decrease in SCR magnitude for the CS+ from trial block 1 to trial block 2. 
Given that the CS+ was always the first stimulus presented, it was not surprising that there 
would be a larger initial SCR and larger subsequent decreases in SCR as participants 
habituated to its novelty.
Acquisition phase
As seen in Table 2, there was a significant stimulus main effect that reflected robust 
differential conditioning as indicated by larger SCR to the CS+, compared to CS−. There 
was also a significant main effect for trial block suggesting that SCR magnitudes differed 
across trials. There was no significant group difference between youth with OCD (M=.53, 
SD=.26) and the CC group (M=.42, SD=.19, η2p=.06). There was a significant stimulus × 
trial block interaction reflecting differing SCR magnitudes to the CS+ and CS− in later 
relative to earlier trial blocks.
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No significant difference was found in the average SCR magnitude to the US between the 
OCD and CC groups for CS+ trials paired with the US (t39=.74, p=.46, d=.24). Although 
there was a significant main effect for trial block (F=6.46, p<.001, η2p=.14), the main effect 
for group (F<1, ns) and the group × trial block interaction (F<1, ns) were not significant.
Extinction Phase
As seen in Table 2, there was a significant stimulus main effect, with the CS+ (M=.49, SD=.
29) producing larger SCRs, compared to the CS− (M=.40, SD=.25). The group × stimulus × 
trial block interaction approached significance; this interaction reached significance when 
the analysis included only the age-and-gender matched samples (n=38; F=2.72, p=.05, η2p=.
07). When the OCD and CC groups were examined separately, different group patterns 
emerged (see Table 3).
For community comparisons, a differential SCR to the CS+ and CS− was observed 
throughout extinction as evidenced by a stimulus main effect. For youth with OCD, a 
significant stimulus × trial block interaction was observed suggesting that the differential 
SCR to CS+ and CS− trials varied across extinction. As can be seen in Figure 1, youth with 
OCD exhibited initially larger SCRs to the CS− during extinction, which diminished to a 
comparable level to that of the CC group at the end of extinction. Curiously, youth with 
OCD exhibited smaller SCRs to the CS+ during initial extinction trial blocks, but produced 
an increasingly large SCR over successive trials that persisted through the end of the 
extinction phase.
Correlations for Acquisition, Extinction, and Differential SCR
During acquisition, there was a moderate positive association between SCR magnitude to 
both the CS+ and CS− with the MASC total score, and a similar association observed 
between the CS+ and OCI-CV total score (see Table 4). During early extinction, there were 
moderate negative associations between the differential SCR and CY-BOCS severity score 
and ASI-3 score. No other associations were significant.
Discussion
To our knowledge, this is the first examination of differential fear conditioning in youth with 
OCD. Similar to adult studies,[14, 15] we found that there was no significant difference 
between youth with OCD and the CC sample in the acquisition of a fear-conditioned SCR. 
Interestingly, youth with OCD did exhibit a different pattern of SCRs during extinction than 
that shown by the CC group. Specifically, community comparisons retained a differential 
SCR to the CS+ and CS− throughout extinction. Although the persistence of a differential 
SCR throughout extinction is not always found among healthy CC participants,[11, 19] it is 
consistent with self-report ratings from studies that have used the same conditioning task.[24] 
In contrast, youth with OCD showed a reversal of SCRs to the CS+ and CS− during early 
extinction followed by increased reactivity to the CS+ and decreased reactivity to the CS− 
over later extinction trials. The persistence of differential fear conditioning throughout 
extinction in both groups suggest that youth, compared to adults, may have greater difficulty 
inhibiting conditioned fear. Notably, the ability to inhibit conditioned fear appeared to be 
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weaker among youth with OCD as evidenced by their larger differential SCR in late 
extinction. Similar to other fear-based psychopathological conditions such as anxiety 
disorders,[10, 43] this finding suggests that inhibitory learning deficits play a central role in 
extinction for youth with OCD. While initial CBT models emphasized within-and-between 
session habituation as the central mechanism for CBT,[44] within- and between-session 
habituation in CBT has not been found to predict treatment outcome for youth with 
OCD.[45, 46] Given the inhibitory learning impairments noted above, inhibitory learning may 
be a key therapeutic component for future CBT protocols for youth with OCD to improve 
treatment outcomes.[47, 48]
Along with inhibitory learning impairments in late extinction, youth with OCD displayed an 
initial reversal of SCRs to the CS+ and CS− during early extinction, i.e., increased reactivity 
to the CS−. A similar reversal has been observed in other studies of youth and attributed to 
an anticipated reversal of the CS-US contingency in the absence of a clear threat cue.[18] 
Youth with OCD may show a threat-related bias in an ambiguous context when the 
association between a CS and US is unclear and a new threat may be anticipated. It is also 
possible that youth with OCD are delayed in their recognition of a shift in association 
between the CS+ and US, which is eventually corrected with further non-reinforced trial 
presentations. Given that the ability to correctly detect new associations plays an important 
role in updating fear memories during extinction, this impaired recognition may serve as a 
harbinger of diminished extinction in CBT, and/or may reflect a biological marker for OCD 
symptom persistence into adulthood. Indeed, youth with fear-based psychopathology who 
fail to develop more complex fear learning capabilities (e.g., fear extinction, discrimination) 
may have a higher risk of symptom persistence into adulthood.[49]
Across participants, anxiety severity was associated with larger SCRs to both the CS+ and 
CS− during the acquisition phase. Similarly, the number and frequency of OCD symptoms 
was associated with larger SCRs to the CS+. Given their similar magnitude, this provides 
empirical support for the relationship between anxiety and OCD phenomenology with 
greater reactivity during fear conditioning. As there have been inconsistent findings 
regarding fear acquisition differences between diagnostic groups, this suggests that 
dimensional factors may be contributing to fear conditioning across youth. Additionally, 
greater OCD severity was associated with smaller differential SCR scores during early 
extinction. A smaller differential SCR suggests that the youth responded similarly to the fear 
and safety cues during early extinction. While this may be partially attributed to greater 
difficulty discriminating between feared stimuli among younger children,[17, 18] it seems 
more likely attributable to impaired inhibitory learning deficits and diminished contingency 
awareness, i.e., the ability to correctly recognize contingencies. The magnitude of 
differential SCR was negatively associated with OCD severity, one of the few replicated 
predictors of poor CBT response,[33, 34] suggesting a possible link between impaired 
inhibitory learning, contingency awareness, and diminished CBT response.
Interestingly, youth with higher anxiety sensitivity scores also showed poorer discrimination 
of the CS+ and CS− during early extinction. Anxiety sensitivity is an important construct in 
adults with OCD and is associated with symptoms,[50] severity,[51] and impairment.[52] 
Based on these findings, youth with greater anxiety sensitivity may be more prone to 
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developing learned fear associations, and/or have difficulty distinguishing between 
threatening and non-threatening stimuli due to anxious arousal. Given that increased anxiety 
sensitivity is a consequence of anxious arousal and the current study elicited anxious arousal 
via an aversive US, increased anxiety sensitivity may serve as a partial explanation for the 
reported findings. Prior associations observed in adults with OCD[50, 51] and findings from 
the current study suggest that there is likely an overlap between anxiety sensitivity and OCD 
severity that warrants further examination.
Several limitations to the reported work should be considered. First, although similar to adult 
OCD studies,[15] the reported study had a small sample that included youth on psychotropic 
medications. Given that psychotropic medications might be expected to reduce SCR 
values,[53] results that trended towards statistical significance may emerge as more robust in 
a larger and/or unmedicated sample. Second, the significance value was set at p=.05 for all 
analyses. Although possibly impacting statistical significance, this would not have impacted 
the magnitude of effect sizes. Third, this study measured anxiety sensitivity using the ASI-3 
to facilitate comparability with prior adult OCD research. Findings may differ from those 
that would be obtained using another anxiety sensitivity measure (e.g., Child Anxiety 
Sensitivity Index). Finally, the magnitude of conditioning can be influenced by study 
specific methodology.[19] Thus, findings from the present study may be limited to our 
conditioning procedure and sample characteristics.
Conclusions
Youth with OCD exhibit normal acquisition but impaired extinction of a fear-conditioned 
SCR. This pattern is suggestive of impairments in inhibitory learning and contingency 
awareness. Additionally, both anxiety severity and OCD symptoms were associated with 
greater overall reactivity, but not differential responding during fear conditioning. 
Furthermore, both greater OCD symptom severity and anxiety sensitivity were associated 
with poorer discrimination between the CS+ and CS− in early extinction. These findings 
highlight several possible directions for future OCD research. First, given variable findings 
in prior conditioning studies of youth with anxiety disorders,[27] replication and extension of 
these findings is warranted. In doing so, it may be useful to capture a trial-by-trial US 
expectancy rating to assess youth's explicit contingency awareness and recognition of 
impaired fear extinction. Second, it would be informative to further examine the role of 
anxiety sensitivity in OCD. Although briefly examined in adults with OCD[42] and included 
in the current study, its investigation in youth and role in treatment is largely unknown. It 
may be that greater anxiety sensitivity is associated with diminished contingency awareness 
due to threat anticipation. Third, given the poorer discrimination of the CS+ and CS− during 
the contingency shift in early extinction, the use of attention/cognitive/threat bias 
modification protocols may be of benefit prior to CBT in order to improve threat and 
contingency recognition. Although attention/cognitive/threat bias modification protocols 
have been found to provide some benefit as stand-alone interventions,[54] they may be of 
greater benefit when used to precede and/or augment CBT.[31, 32] Additionally, there is a 
growing body of evidence that highlights the importance of inhibitory learning in exposure 
therapy.[47] Although predominantly focused on adults with anxiety disorders,[47] the 
McGuire et al. Page 9
Depress Anxiety. Author manuscript; available in PMC 2017 November 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
incorporation of inhibitory-learning based CBT may prove beneficial in reducing inhibitory 
deficits and thereby maximize the therapeutic benefit for youth with OCD.[48]
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Figure 1. 
Skin Conductance Responses During Habituation, Acquisition, and Extinction Phases for 
Youth with OCD (n=19) and Community Control Youth (n=22)
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Table 1
Characteristics for Youth with OCD and Community Comparisons (N = 41)
OCD
Group
(n = 19)
Community
Comparison
Group
(n = 22)
N (%) N (%) χ2 p
Male Participants 10 (53%) 10 (45%) 0.21 .65
Race/Ethnicity
  White/Caucasian 18 (95%) 16 (73%) 3.49 .06
    Non-Hispanic 17 (89%) 21 (95%) 0.54 .46
Psychiatric Diagnoses
  OCD 19 (100%) 0 (0%) 41.00 < .01
  Any Anxiety Disordera 6 (32%) 6 (27%) 0.09 .76
  Attention Deficit Hyperactivity Disorder 2 (11%) 0 (0%) 2.44 0.12
  Depressive Disorders 1 (5%) 0 (0%) 1.19 0.28
  Chronic Tic Disorder 2 (11%) 0 (0%) 2.44 0.12
  Disruptive Behavior Disorder 1 (5%) 0 (0%) 1.19 0.28
Psychiatric Medication
    SRI 8 (42%) 0 (0%) 11.51 < .01
    Antipsychotic 2 (11%) 0 (0%) 2.44 .12
    Stimulant 2 (11%) 0 (0%) 2.44 .12
    Benzodiazepine 1 (5%) 0 (0%) 1.19 .28
Mean (SD Mean (SD t p
Age 13.26 (3.07) 12.59 (2.24) 0.81 .43
CY-BOCS Total Score 23.42 (6.31) 0.00 (0.00) 16.18 < .01
OCI-CV Total Scoreb 14.33 (7.78) 9.32 (4.59) 2.41 .02
MASC Total T-Scorec 55.53 (17.07) 50.56 (8.58) 1.03 .31
ASI-3Total Scored 12.60 (11.98) 9.55 (7.56) 0.88 .39
Note. OCD = Obsessive-Compulsive Disorder; SRI = Serotonin Reuptake Inhibitor; CY-BOCS = Children's Yale-Brown Obsessive Compulsive 
Scale; OCI-CV = Obsessive Compulsive Inventory-Child Version; MASC = Multidimensional Anxiety Scale for Children; ASI-3 = Anxiety 
Sensitivity Index-3rd Edition.
aAny Anxiety Disorder = Specific Phobia, Social Anxiety Disorder, Generalized Anxiety Disorder, Separation Anxiety Disorder, or Anxiety 
Disorder - Not Otherwise Specified. Community Controls only had Specific Phobias.
b1 participant did not complete the OCI-CV.
c2 participants did not complete the MASC.
d4 participants did not complete the ASI-3.
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Table 2
ANOVA Results for Comparisons of SC Responses for All Three Phases (N = 41)
Habituation Phase F p η2p
Group < 1.00 NS .01
Stimulus < 1.00 NS < .01
Trial Block 3.84 .06 .09
Stimulus × Trial Block 9.19 .004 .19
Group × Stimulus 1.34 .26 .03
Group × Trial Block < 1.00 NS .02
Group × Stimulus × Trial Block < 1.00 NS < .01
Acquisition Phase F p η2p
Group 2.59 .12 .06
Stimulus 9.80 .003 .20
Trial Block 5.60 .002 .13
Stimulus × Trial Block 6.18 < .001 .14
Group × Stimulus < 1.00 NS .01
Group × Trial Block 1.87 .14 .05
Group × Stimulus × Trial Block 1.25 .29 .03
Extinction Phase F p η2p
Group 1.48 .23 .04
Stimulus 4.49 .04 .10
Trial Block 1.66 .19 .04
Stimulus × Trial Block 2.26 .09 .06
Group × Stimulus 1.24 .27 .03
Group × Trial Block < 1.00 NS .02
Group × Stimulus × Trial Block 2.54 .06 .06
Note. NS = Not significant.
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Table 3
Skin Conductance Response Separated by Diagnostic Group during Extinction Phase
Youth with OCD (n = 19) F p η2p
Stimulus < 1.00 NS .03
Trial Block 1.15 .34 .06
Stimulus × Trial Block 4.34 .01 .19
Community Comparisons (n = 22) F p η2p
Stimulus 4.94 .04 .19
Trial Block 1.22 .31 .06
Stimulus × Trial Block < 1.00 NS < .01
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